Drug Product Zenitsu Classification Quiz
7 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Calculate the DSV and determine the BCS class of drug product Zenitsu.

volume; BCS Class X

Drug product Miraidon is a film-coated tablet containing 100 mg.

True

What was the outcome of the Bioequivalence Studies for Miraidon?

  • No studies were conducted.
  • Results were above the acceptance criteria.
  • Results were below the acceptance criteria.
  • Results were within the acceptance criteria. (correct)
  • Calculate the DSV and determine the BCS class of the drug product Zenitsu.

    <p>Volume; BCS Class X</p> Signup and view all the answers

    What is the solubility of drug product Zenitsu in 0.1 N HCl at pH 2?

    <p>0.0492 g/mL</p> Signup and view all the answers

    The drug product Miraidon has undergone Bioequivalence Studies.

    <p>True</p> Signup and view all the answers

    The film-coated tablet of drug product Miraidon contains ______ mg of drug.

    <p>100</p> Signup and view all the answers

    Study Notes

    Drug Product Zenitsu

    • Available strengths: 8 mg, 16 mg, and 32 mg.
    • Absorption rate: 65%.
    • Solubility data provided for various pH levels and media:
      • 0.1 N HCl, pH 1: Solubility is 0.0472 g/mL.
      • 0.1 N HCl, pH 2: Solubility is 0.0492 g/mL.
      • 0.15 M acetate buffer, pH 4: Solubility is 0.0568 g/mL.
      • 0.15 M phosphate buffer, pH 6: Solubility is 0.0608 g/mL.
      • 0.15 M phosphate buffer, pH 8: Solubility is 0.0560 g/mL.
    • Drug's DSV (Dose Solubility Volume) needs to be calculated for classification.
    • BCS (Biopharmaceutical Classification System) class determination follows solubility and absorption characteristics.

    Drug Product Miraidon

    • Formulation: Film-coated tablet containing 100 mg of active pharmaceutical ingredient (API).
    • Underwent Bioequivalence Studies with a comparator drug.
    • Results of Bioequivalence Studies met acceptance criteria outlined in the study protocol.

    Drug Product Zenitsu

    • Available strengths: 8 mg, 16 mg, and 32 mg.
    • Absorption rate: 65%.
    • Solubility data provided for various pH levels and media:
      • 0.1 N HCl, pH 1: Solubility is 0.0472 g/mL.
      • 0.1 N HCl, pH 2: Solubility is 0.0492 g/mL.
      • 0.15 M acetate buffer, pH 4: Solubility is 0.0568 g/mL.
      • 0.15 M phosphate buffer, pH 6: Solubility is 0.0608 g/mL.
      • 0.15 M phosphate buffer, pH 8: Solubility is 0.0560 g/mL.
    • Drug's DSV (Dose Solubility Volume) needs to be calculated for classification.
    • BCS (Biopharmaceutical Classification System) class determination follows solubility and absorption characteristics.

    Drug Product Miraidon

    • Formulation: Film-coated tablet containing 100 mg of active pharmaceutical ingredient (API).
    • Underwent Bioequivalence Studies with a comparator drug.
    • Results of Bioequivalence Studies met acceptance criteria outlined in the study protocol.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on the pharmacokinetics of the drug product Zenitsu. This quiz focuses on the calculations of DSV (Drug Solubility Volume) and determining the BCS class based on its solubility and absorption characteristics. Prepare to apply your understanding of drug formulation and classification.

    Use Quizgecko on...
    Browser
    Browser